Mirae Asset Global ETFs Holdings’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.71M Buy
22,202
+1,799
+9% +$353K 0.01% 883
2026
Q1
$4M Buy
20,403
+873
+4% +$170K 0.01% 883
2025
Q4
$3.39M Sell
19,530
-25
-0.1% -$4.55K 0.01% 938
2025
Q3
$3.73M Buy
19,555
+1,267
+7% +$225K 0.01% 898
2025
Q2
$3.29M Sell
18,288
-8,933
-33% -$1.55M 0.01% 870
2025
Q1
$4.61M Buy
27,221
+860
+3% +$141K 0.01% 784
2024
Q4
$3.98M Sell
26,361
-24,489
-48% -$3.81M 0.01% 846
2024
Q3
$7.89M Sell
50,850
-6,271
-11% -$937K 0.02% 633
2024
Q2
$7.82M Buy
+57,121
New +$7.82M 0.02% 611

Other funds holding DGX

Mirae Asset Global ETFs Holdings's DGX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Quest Diagnostics (DGX) stake by 8.8% in Q2 2026, buying an estimated $353K and bringing the position to 22,202 shares worth $4.71M. The position accounts for 0.01% of the portfolio, ranked #883.

Mirae Asset Global ETFs Holdings first reported a position in DGX in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.89M in Q3 2024. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 22,202 shares of Quest Diagnostics worth $4.71M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 1,799 Quest Diagnostics shares in Q2 2026, an estimated $353K.
  • Quest Diagnostics made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #883 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Quest Diagnostics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Quest Diagnostics position peaked at $7.89M in Q3 2024.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.